<DOC>
	<DOCNO>NCT02491788</DOCNO>
	<brief_summary>The purpose study test hypothesis ingestion wake-inhibiting drug suvorexant 30 minute prior daytime sleep initiation individual work overnight shift significantly improve objective ( total sleep time , sleep efficiency , wake sleep onset ) subjective ( sleep quality ) measure daytime sleep .</brief_summary>
	<brief_title>Examination Effectiveness Suvorexant Improving Daytime Sleep Shift Workers</brief_title>
	<detailed_description />
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Sleep Disorders , Circadian Rhythm</mesh_term>
	<mesh_term>Suvorexant</mesh_term>
	<criteria>Aged 2060 ( old individual exclude due alter sleeprelated circadian signal ) Males females Shift worker Minimum three month prior shift work Will work minimum four night per week 32 hour night shift per week study `` Night work '' define least six hour work occur 8 PM 8 AM longer 12 hour shift Presence DSM5 define Circadian Rhythm SleepWake Disorder : Shift Work Type Insomnia ( SE &lt; 88 % ) attempt daytime sleep excessive sleepiness nocturnal wake Currently plan become pregnant Currently breastfeed Inadequate opportunity ( &lt; 7 hour ) daytime sleep shift work Use sleep aid study period . Includes need continuous use prescription , nonprescription , naturopathic pharmacotherapies Diagnosis detection ( study ) sleep disorder breathing ( AHI &gt; 10 ) home sleep testing ; referral clinical sleep program offer Diagnosis narcolepsy Restless Legs Syndrome &gt; 600 mg caffeine intake per night shift use prescription stimulant medication night shift Rotational irregular work shift study Use digoxin six month prior study Use strong ( e.g. , etoconazole , itraconazole , posaconazole , clarithromycin , nefazodone , ritonavir , saquinavir , nelfinavir , indinavir , boceprevir , telaprevir , telithromycin , conivaptan ) moderate ( e.g. , amprenavir , aprepitant , atazanavir , ciprofloxacin , diltiazem , erythromycin , fluconazole , fosamprenavir , grapefruit juice , imatinib , verapamil ) CYP3A inhibitor CYP3A inducer ( e.g. , rifampin , carbamazepine , phenytoin ) six month prior study Severe hepatic impairment Unstable severe medical psychiatric condition</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>